Mark N Wegman insider trades: Biospecifics Technologies (BSTC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 24, 2019 | BSTC | ↓ Sell | 7,800 | $61.09 | $477K | Direct | May 28, 2019 (4d) |
| May 22, 2019 | BSTC | ↓ Sell | 1,200 | $63.70 | $76K | Direct | May 23, 2019 (1d) |
| May 21, 2019 | BSTC | ↓ Sell | 6,000 | $64.04 | $384K | Direct | May 22, 2019 (1d) |
| Sep 11, 2018 | BSTC | ↓ Sell | 6,500 | $57.52 | $374K | Direct | Sep 11, 2018 (0d) |
| Aug 23, 2018 | BSTC | ↓ Sell | 8,500 | $52.63 | $447K | Direct | Aug 23, 2018 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark N Wegman's insider trades
Mark N Wegman is a director at Biospecifics Technologies (BSTC). Since Aug 23, 2018, Mark has reported no open-market purchases and 5 sales worth $1.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), option exercises (2 filings), shares returned to the company (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BSTC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.